Executives and professionals of the biopharma and medical device realm are invited to attend the 8th Decentralized & Hybrid Clinical Trial conference organized by DGE, May 15-16, 2024, in Philadelphia, PA. The event focuses on optimizing the technical processes, regulatory compliance, and design adaptability of remote clinical trials.
The conference is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing b2b events. The global event company caters to the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries.
During COVID-19, remote and decentralized clinical trials (DCTs) came into practice. Since then, the application of decentralized methods for clinical trials has grown phenomenally. Thus, clinical trial teams have to be prepared and equipped to incorporate the relevant technologies for decentralized methods. This conference explores insights into challenges and offers solutions for selecting the right technologies for patients and sites, understanding FDA guidelines, overcoming logistical hurdles, and much more.
Experts conducting speaker sessions will also talk about how the power of AI can be harnessed for various clinical trial processes such as attaining patient data in DCTs, and also when solving issues of tech affordability, bias, and inconsistent data management. Additional topics include the importance of home sampling for decentralized trials, and uses of eConsent.
The event is meticulously curated to address challenges and offer solutions to the clinical trial industry. DGE offers a phenomenal networking platform to meet, learn, and connect with the right professionals and influencers. Connect with industry leaders, showcase unique ideas and presentations, and get the latest updates to stay ahead of the competition.
To know more, please visit https://ibn.fm/r97GX.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN